Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How should clinicians interpret clinical trials?

R M Califf1

  • 1Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.

Cardiology Clinics
|August 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical, electrocardiographic, and biochemical data for immediate risk stratification in acute coronary syndromes.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·2001
Same author

Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy.

The American journal of cardiology·2001
Same author

Introduction: evidence to practice in acute coronary syndromes.

The American journal of cardiology·2001
Same author

Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators.

Journal of the American College of Cardiology·2001
Same author

Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto I) and assessment of the safety of a new thrombolytic (assent 2) studies.

Circulation·2001
Same author

Statistical approaches and policies for the operations of Data and Safety Monitoring Committees.

American heart journal·2001
Same journal

At the Edge of the Possible: A New Standard for Cardiovascular Critical Care.

Cardiology clinics·2026
Same journal

End-of-Life Care in the Cardiovascular Intensive Care Unit.

Cardiology clinics·2026
Same journal

Strategies to Reduce Failure to Rescue after Cardiac Surgery.

Cardiology clinics·2026
Same journal

Embracing Enhanced Recovery After Cardiac Surgery Program.

Cardiology clinics·2026
Same journal

Post-Heart Transplantation Intensive Care Unit Recovery: A Phase-Based Approach.

Cardiology clinics·2026
Same journal

A Practical Guide to Intensive Care Unit Management after Left Ventricular Assist Device Implantation.

Cardiology clinics·2026
See all related articles

Clinicians should prioritize randomized clinical trials for treating ischemic heart disease due to their robust evidence. When unavailable, consider observational studies and ensure research design quality for reliable therapeutic decisions.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Research Methodology

Background:

  • Cardiovascular medicine is rapidly advancing, presenting clinicians with vast amounts of new therapy information.
  • Effective treatment of ischemic heart disease requires careful evaluation of available evidence.

Purpose of the Study:

  • To outline a hierarchy of evidence for selecting therapies in ischemic heart disease.
  • To emphasize the critical elements of good study design in clinical research.

Main Methods:

  • Review of evidence hierarchy for clinical decision-making.
  • Identification of key components of robust study design.

Main Results:

  • Randomized clinical trials (RCTs) offer the highest level of unbiased evidence.

Related Experiment Videos

  • Observational studies, historically controlled studies, case series, and case reports follow in descending order of evidence strength.
  • Essential design elements include clear questions, adequate sample size, appropriate criteria, careful data collection, and analytical allowances for complex patient populations.

    • Conclusions:

    • Prioritize randomized clinical trials for ischemic heart disease treatment.
    • When RCTs are absent, evaluate other study designs based on their methodological rigor.
    • Adherence to principles of good study design is crucial for reliable clinical evidence.